NeuRizer has released its December 2022 Quarterly Report. Highlights from this period include:
- Progress with potential strategic and funding partners
- FEED, BFS and site development progress
- Federal Government Research and Development Advance Finding awarded to NeuRizer, allowing claimable expenditure that provides significant funding through tax rebates over 3 years from 2021/22
- NeuRizer admitted to S&P/ASX Agribusiness Index
- Private Placement
The report also includes an extensive update on Australia’s and international urea markets.